We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+0.97%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$40.1B
AUM Growth
-$4.93B
(-11%)
Cap. Flow
-$4.88B
Cap. Flow
% of AUM
-12.17%
Top 10 Holdings %
Top 10 Hldgs %
19.14%
Holding
959
New
32
Increased
238
Reduced
614
Closed
39
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$192M |
| 2 |
Fiserv Inc
FISV
|
+$93.4M |
| 3 |
American Express
AXP
|
+$91.1M |
| 4 |
Prologis
PLD
|
+$86.5M |
| 5 |
AbbVie
ABBV
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$197M |
| 3 |
Apple
AAPL
|
+$164M |
| 4 |
RTN
Raytheon Company
RTN
|
+$154M |
| 5 |
Chevron
CVX
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Financials | 15.72% |
| 3 | Consumer Discretionary | 12.22% |
| 4 | Healthcare | 10.98% |
| 5 | Communication Services | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Charles Schwab
SCHW
$163B
| $325M | 0.81% |
7,773,320
+1,222,874
| +19% | +$49.4M |
2017 Q3
8 quarters
|
|
27
TJX Companies
TJX
$159B
| $323M | 0.8% |
5,789,064
-704,888
| -11% | -$38.4M |
2017 Q3
8 quarters
|
|
28
CME Group
CME
$104B
| $315M | 0.79% |
1,490,036
-278,371
| -16% | -$58.2M |
2017 Q3
8 quarters
|
|
29
Citigroup
C
$207B
| $315M | 0.78% |
4,554,011
-73,656
| -2% | -$5.01M |
2017 Q3
8 quarters
|
|
30
Boston Scientific
BSX
$64B
| $314M | 0.78% |
7,703,977
-318,056
| -4% | -$13.5M |
2017 Q3
8 quarters
|
|
31
SLB Ltd
SLB
$71.8B
| $311M | 0.77% |
9,092,515
-26,814
| -0.3% | -$980K |
2017 Q3
8 quarters
|
|
32
Mondelez International
MDLZ
$80.4B
| $306M | 0.76% |
5,536,976
+621,688
| +13% | +$34M |
2017 Q3
8 quarters
|
|
33
Yum China
YUMC
$15.1B
| $302M | 0.75% |
6,649,427
-1,751,269
| -21% | -$78.2M |
2017 Q3
8 quarters
|
|
34
AT&T
T
$161B
| $296M | 0.74% |
10,371,885
-1,295,102
| -11% | -$34.3M |
2017 Q3
8 quarters
|
|
35
Philip Morris
PM
$312B
| $283M | 0.71% |
3,732,418
+480,611
| +15% | +$38.1M |
2017 Q3
8 quarters
|
|
|
FRC
36
DELISTED
First Republic Bank
FRC
| $281M | 0.7% |
2,904,900
-220,563
| -7% | -$20.9M |
2017 Q3
8 quarters
|
|
37
Tenaris
TS
$28.9B
| $278M | 0.69% |
13,124,658
+2,579,511
| +24% | +$60.4M |
2017 Q3
8 quarters
|
|
38
McDonald's
MCD
$172B
| $263M | 0.66% |
1,225,074
-91,201
| -7% | -$19.6M |
2017 Q3
8 quarters
|
|
39
Eli Lilly
LLY
$1.12T
| $261M | 0.65% |
2,330,845
+16,789
| +0.7% | +$1.87M |
2017 Q3
8 quarters
|
|
40
Banco Santander Chile
BSAC
$15.5B
| $260M | 0.65% |
9,291,125
-300,293
| -3% | -$8.67M |
2017 Q3
8 quarters
|
|
|
WUBA
41
DELISTED
58.com Inc
WUBA
| $260M | 0.65% |
5,273,498
+1,229,691
| +30% | +$68.1M |
2017 Q3
8 quarters
|
|
42
Intercontinental Exchange
ICE
$88.9B
| $260M | 0.65% |
2,813,438
-924,234
| -25% | -$84.4M |
2017 Q3
8 quarters
|
|
43
CMS Energy
CMS
$21B
| $258M | 0.64% |
4,026,386
-830,407
| -17% | -$50.4M |
2017 Q3
8 quarters
|
|
44
PepsiCo
PEP
$175B
| $254M | 0.63% |
1,853,835
-182,387
| -9% | -$24.2M |
2017 Q3
8 quarters
|
|
45
EOG Resources
EOG
$80.1B
| $254M | 0.63% |
3,423,088
+158,458
| +5% | +$12.8M |
2017 Q3
8 quarters
|
|
46
Estee Lauder
EL
$38.8B
| $250M | 0.62% |
1,254,960
-259,292
| -17% | -$49.6M |
2017 Q3
8 quarters
|
|
47
Constellation Brands
STZ
$21.9B
| $249M | 0.62% |
1,198,640
-17,059
| -1% | -$3.43M |
2017 Q3
8 quarters
|
|
48
Broadcom
AVGO
$1.64T
| $238M | 0.59% |
8,615,540
-1,122,630
| -12% | -$31.9M |
2018 Q3
4 quarters
|
|
49
Bristol-Myers Squibb
BMY
$124B
| $230M | 0.57% |
4,530,884
-355,116
| -7% | -$16.7M |
2017 Q3
8 quarters
|
|
50
Marvell Technology
MRVL
$217B
| $225M | 0.56% |
9,001,326
+441,757
| +5% | +$11.1M |
2018 Q1
6 quarters
|
|
Similar funds
Aberdeen Group's Q3 2019 Portfolio in Review
As of Q3 2019, Aberdeen Group held 959 positions worth $40.1B, down 11% from $45B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Aberdeen Group withdrew a net $4.88B in Q3 2019, closing 39 positions and reducing 614 holdings. Its most notable exit was L3Harris, an estimated $88.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $40.7M.
- Aberdeen Group's largest Q3 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,493,397 shares worth $40.7M.
- Aberdeen Group added most to Fidelity National Information Services in Q3 2019, an estimated $192M increase.
- Aberdeen Group's biggest Q3 2019 reduction was Wells Fargo, cutting an estimated $206M.
- Aberdeen Group fully exited L3Harris in Q3 2019, selling an estimated $88.4M.
- Aberdeen Group's ten largest holdings make up 19% of its $40.1B portfolio in Q3 2019.
- Aberdeen Group opened 32 new positions and closed 39 in Q3 2019.
- Aberdeen Group's portfolio value fell 11% quarter-over-quarter to $40.1B.
Based on Aberdeen Group's 13F filing for Q3 2019, filed 13 Nov 2019.